Distribution of 3H-bleomycin among organs of normal mice of various ages and old mice bearing skin carcinoma or sarcoma induced by 20-methylcholanthrene was studied and the ratios of the antibacterial activity to the radioactivity were examined. Higher concentration was shown in carcinoma than in sarcoma and in the former more than 50 % of 3H-bleomycin remained in an active form exhibiting antibacterial activity. Slight or no activity was observed in sarcoma. The selective effect of bleomycin on mouse skin carcinoma induced by 20-methylcholanthrene was thus suggested to be due to the low ability of the tumor to inactivate bleomycin and probably also to the high uptake in this tumor. Differences were also observed among distributions of 3H-bleomycin in lung and skin of mice of different ages. The higher concentration of its active form was shown in lung and skin of old mice at higher rate than in those of young ones.
three more bleomycins (A2'-a, A2'-b and B6) were found. These bleomycins resemble each other in physicochemical properties, and the chemistry of A2 has been studied in the greatest ditail. information on the mode of action does not indicate the mechanism of the selective effect of bleomycin on squamous cell carcinoma.
In this paper, studies on the mechanism of the selective action on squamous cell carcinoma are reported.
Materials and Methods
3H-Bleomycins : Bleomycin A2 and bleomycin mixture which were prepared by Nipponkayaku Co. were tritiated and purified by CM-Sephadex chromatography as reported by
Umezawa et aPJ The 3H-bleomycin mixture consisted of 48.5 % A2, 27.0 % B2, ll.8 % Al9 3.4% Bi, 3.9% A2' and 3.4 % B4. Tritiated bleomycins decompose during storage and the decomposition can be shown by thin-layer chromatography using a solvent system of 10 % ammonium acetate-10 % ammonia-methanol (9 : 1 : 10). Therefore, the bleomycins were employed within two weeks after their purification.
Method of testing distribution of 3H-bleomycin A2 in organs of mice: A half ml of tritiated bleomycin in saline was subcutaneously injected, and 1 hour thereafter, the mice were killed by bleeding from the axilla vein. All organs were ground and extracted twice with 0.1m phosphate buffer of pH 7.0 using the same weight as the organ. The radioactivity of each extract was determined by a Beckmann Liquid Scintillation System CPM-200 (LS-ll).
The antibacterial activity was determined by the cylinder plate method using Bacillus subtilis as the test organism and the corresponding bleomycin as the standard. The residues after the extraction of the ground organs were hydrolyzed in 1N HC1 in a sealed tube at 100°C for 18 hours and the radioactivity of the hydrolysate was determined. Radioactivities and antibaterial activities of feces, urine and serum were also examined.
Method of testing distribution of 3H-bleomycin mixture in mice bearing carcinoma or sarcoma induced by 20-methylcholanthrene: As it was reported by Ichikawa et al.17) , a saturated solution of 20-methylcholanthrene in acetone which was kindly supplied by
Yoshida and Odajima, Sasaki Institute, Tokyo, was streaked twice a week for 10 weeks on the skin of 10-week-old mice. Twenty four weeks after the treatment (44 weeks after birth) a mouse bearing squamous cell carcinoma was used for the experiment. To another group of 10-week-old mice 0.1 ml of 20-methylcholanthrene suspension (10jug/ml in 30 % Tween 80) was subcutaneously injected, and 17 weeks after the injection (27 weeks after birth) a mouse in which a skin sarcoma was induced was used for the experiment. The distribution of copper-containing 3H-bleomycin mixture in organs and tumors of these mice was examined by the same method described above.
Inactivation of bleomycins A2, A5, B2, B4 by tissue homogenates : Liver, kidney, lung and skin of mice were homogenized with phosphate buffer (pH 6.8, 1/15m) using 3 times the weight of each organ and centrifuged at 900g. The supernatant was incubated for 3 minutes at 37°C and bleomycin was added at 1,000Ag/ml and further incubated at 37°C for 30 minutes. The residual bleomycin was determined by the cylinder-plate method described 
Results

Distribution
of 3H-Bleomycin A2 among Organs of Mice Using two mice each weighing 19g, 2.0mg of tritiated bleomycin A2 (4.60XlO6 dpm in total) was subcutaneously injected and the syringe was then washed with water. Then, the residual radioactivity in the wash water was 0.93XlO6 dpm and therefore, the amount injected to two mice was 1.59mg. The organs taken from two mice were combined, ground, extracted twice with 1/10M phosphate buffer using the same weight as the organs and centrifuged at 3,000r.p.m. for 20 minutes. The residue of each organ was hydrolyzed and radioactivity of the hydrolysate was determined. As shown in Table 1 , totally 1.43mg of the injected bleomycin was found in the extracts of organs, serum, urine and feces, and 0.16mg was found in the hydrolysates of the residues. Thus, 100% of the injected bleomycin as measured by radioactivity was recovered. From the results it can be seen that bleomycin in the hydrolysate is high in kidney, urinary bladder and skin. However, if we compare the amounts of bleomycin extracted with those remaining in the residues after the extraction, as shown in Table 2 , there was no organ which contained particularly large amounts of Total | 3,300 | 1, 434. 4 * 2.60xl06 dpm/mg ; 3.67xlO6 dpin was introduced subcutaneously intotwo mice ; The mice were killed 1 hour thereafter.
bleomycin in the residue after the extraction. The lowest amount was found in the eye. The amounts of bleomycin in urinary bladder and kidney vary in different experiments, due to contamination of urine containing bleomycin at high concentration. Therefore, the amounts of bleomycin shown in kidney and urinary bladder do not indicate the true values in the tissues of these organs. The results shown in Table 2 indicate that there is no organ which strongly binds bleomycin so that the bleomycin can not be extracted.
High concentrations of 3H-bleomycin was measured by radioactivity in extracts of kindey, urinary bladder, skin and peritoneum. As already described, the values of bleomycin in kidney and urinary bladder do not indicate the true concentration in these tissues.
The high concentrations in skin and peritoneum indicate the bleomycin is taken up by these tissues at higher concentrations than by the others. If the measurement of 3H-bleomycin using antibaterial activity is designated as the active form, then as shown by the ratios of concentrations of the antibacterial activity to the radioactivity in Table 1 , the active form is high in skin and lung. In the other The radioactivity of the hydrolysate of the residue was determined.
are shown inTable 3. In this experiment, the local skin and the peritoneum of 1cm in diameter around the area of injection were examined separately from other parts of these tissues. As shown in Table 3 , high concentrations were shown in lung, skin and carcinoma, the figures being as 25.5//g/g, 17.7jug/g, and 15.9^g/g respectively. As shown in Table 3, except  for kidney  and urinary  bladder  which is contaminated with urine, bleomycin which showed antibacterial activity was detected only in lung, skin and carcinoma. In serum, the concentration of bleomycin shownby antibacterial activity was higher than that shown by radioactivity measurements. Among bleomycins in the bleomycin mixture used, A2 is the main component. Other bleomycins which have stronger antibacterial activity are thought to be differentially reduced in serum. In urine, the concentration of bleomycin shownby the radioactivity was slightly lower than that shown by the antibacterial activity. In another experiment, the identical quantity of the same 3H-bleomycin mixture was subcutaneously injected into a mouse weighing 35.0g and bearing a sarcoma induced by the subcutaneous injection of 20-methylcholanthrene. The radioactivities and antibacterial activities of extracts of organs and excretion were examined. Totally, 93.5 % of the injected radioactivity was recovered in the extracts. The result is shown in Table 4 . Except for concentration in sarcoma, the results were substantially the same as that seen in the experiment with the mousebearing squamouscell carcinoma.
In the sarcoma, a much lower concentration (4.5jug/g) than that in the skin (26.9Mglg) was observed and the active form of bleomycin was not detected in the sarcoma.
Another minor difference from the previous experiment is that the concentrations shown by the antibacterial activity in serum and urine were slightly lower than those
shown by the radioactivity.
The same experiments were repeated in the other two mice bearing carcinoma and the other two mice bearing sarcoma. The results of the distribution of 3H-bleomycin in various organs were substantially same as those described in Tables 3  and 4 . The distribution in carcinoma and sarcoma shown in Table 5 includes data from all the experiments. The total concentration shown by radioactivity was higher in the squamouscell carcinoma than in sarcoma. A more marked difference was found in the concentration of the active form which was significantly higher in the carcinoma than in the sarcoma.
Distribution of 3H-Bleomycin Mixture in Mice of Different Ages Distribution of 3H-bleomycin mixture in mice weighing 19g was reported in a previous paper by Umezawa et al.18\ and distribution of 3H-bleomycin A2 in mice b is the concentration determined by the antimicrobial activity and a is that by the radioactivity and b/a indicates the ratio of the active bleomycin to the total bleomycin. In the Exp. 1, the specific activity of bleomycin was 6.70x106dpm/mg and the doses were as follows : 52.76mg/kg for 3 weeks mouse, 49.71 mg/kg for 5 weeks mouse, 54.28mg/kg for 28 weeks mouse. In Exp. 2, the specific activity of bleomycin was 6.56xlO6 dpm/mg and doses were as follows :52.77 mg/kg for 3 weeks, 5 weeks and 28 weeks mouse. It was subcutaneously injected and 1 hour thereafter, the concentrations of organs were determined by the radioactivity and the antibacterial activity. Table 6 . The organs of the youngest mice have the greatest ability to inactivate bleomycin. The ability to inactivate bleomycin was the weakest in the oldest mice of 28 weeks, and 50~64% and 46~49% of bleomycin remained in an active form in the lung and skin respectively. Moreover, a higher concentration was shownin the skin of the oldest mice than in that of younger ones, and in the peritoneum of the oldest mice 15~22%of bleomycin was detected as the active form.
Extraction of A Bleomycin-Inactivating Enzyme and Isolation of Inactivated Bleomycin B2
The percent of residual bleomycins after inactivation by tissue homogenates at of bleomycin B2 per min. 7) u/mg means u/mg asprotein. Fig.2 . Activity of the proteins obtained from squamous cell carcinoma and sarcoma induced by 20-methylcholanthrene in mice skin to inactivate bleomycin (one unit inactivates 1.0jug of bleomycin B2 in 1minute).
37°C for 30 minutes are shown in Table 7 . Amongthe bleomycins studied, namely A2, A5, B2 and B4, bleomycin B2 is most rapidly inactivated. Amongthe homogenates of lung, skin, liver, spleen and kidney, the most rapid inactivation occurred in kidney and liver homogenates and the inactivation was the slowest in lung and skin homogenates.
The bleomycin-inactivating enzyme was extracted from homogenate of liver of mice by the procedure described in the previous section. The activity of the extract and the yield of the enzyme at each step of the extraction are shown in Table 8 . The optimumpH of enzyme was 7---7.5, and the optimumtemperature was 37°C. The enzyme, purified by DEAEcellulose chromatography, was very unstable. Therefore, the enzyme obtained by Sephadex G-25 chromatography was employed for the experiments. The comparative inactivation of bleomycins A2, A5 and B2 was studied and the results are shown in Fig. 1 . Among these bleomycins, B2 was most rapidly inactivated.
After the inactivation, ammonia was determined using the Conway microdiffusion method followed by titration or by spectrometry after the ninhydrin reaction. One mole of ammonia was found to be released during the inactivation. Weattempted to isolate the inactivated bleomycin B2 to find the chemical difference from bleomycin B2. Two hundred mg of bleomycin B2 was incubated with 40ml of the enzyme solution (1,600mg as protein) and 60ml of 1/15M phosphate buffer for one hour at 37°C. A hundred ml of methanol was added and the supernatant was concentrated to 20ml. The inactivated and the residual bleomycins were adsorbed on IRC-50 resin in H+ form and eluted with 0.05N hydrochloric acid-acetone (1 : 1). After neutralization with IR-45 resin in OH"form, the eluate was evaporated in vacuo to dryness. The powder was dissolved in 50mlof distilled water and passed through aGM-Sephadex G-25 column (240ml) and the inactivated bleomycin was eluted by raising the concentration of ammoniumformate from 0.05M to 1.0m. Carcinoma and sarcoma were induced by 20-mthylcholanthrene and half of each tumor was homogenized by the procedure described above. From the homogenate, the bleomycin-inactivating enzymewas extracted by centrifugation at 105,000 g, protamine treatment and precipitation with 35~60 % saturation of ammoniumsulfate as described Fig. 2 . The other half of tumor was sent to the Department of Pathology, the First Tokyo National Hospital, for the histological diagnosis. As shown in Fig. 2 , the activity of the protein obtained from 10 sarcomas was significantly higher than that of the 13 carcinomas examined. Only one exception which was not shown in the figure was found in one carcinoma which yielded a protein having an activity of 3.0u/mg.
Discussion
As reported in previous papers4~12), bleomycin causes strand scission of DNA in vitro, and the scission of DNA can also be shown in vivo15). At a low concentration bleomycin inhibits DNAligase. These effects are similar to the effects of radiation. This resemblance suggests that there may be human tumors which would be sensitive both to radiation and to bleomycin. However, the selective effect of bleomycin on squamous cell carcinoma was found to be due to another reason. Before the clinical study of bleomycin was initiated, distribution of bleomycin among organs of mice was studied and a high concentration in lung was found. It was therefore thought that bleomycin might be effective against lung tumors. Later, the effect on penile cancer was observed by Ichikawa and a study of the distribution of bleomycin in mice showed high concentrations in the skin19).
In these studies, concentrations of bleomycin were determined by the antibacterial activity. Ichikawa and Takeuchi17) have confirmed that bleomycin is effective against squamous cell carcinoma in mice skin induced by 20-methylcholanthrene, but not effective on sarcoma in mice skin induced by the same chemical. Now, as shown in Tables 3, 4 , and 5, it was experimentally proved that the distribution of 3H-bleomycin in the active form is significantly higher in the carcinoma than in the sarcoma. Moreover, the result suggests a higher distribution of total bleomycin in carcinoma than in sarcoma. Significantly higher concentration of active bleomycin in the carcinoma than in the sarcoma is thought to be due to the lower content of a bleomycin-inactivating enzyme in the former, because the activity of proteins extracted from the sarcoma was significantly higher than that extracted from carcinoma (Fig. 2) . Thus, the results of the studies on distribution of radioactive bleomycin and on enzyme proteins inactivating bleomycin indicate that the selective effect of bleomycin on squamous cell carcinoma is dependent on the low activity of this tumor to inactivate bleomycin and probably also on the high distribution of total bleomycin in this tumor. Study of distribution of bleomycin also gave useful information on toxicity of bleomycin. Among various organs, after the injection of 3H-bleomycin, active bleomycin was higher in lung and skin than in other organs.
Also, in in vitro experiments, inactivation of bleomycin was slowest in homogenates of lung and skin as compared with homogenates of liver, spleen and kidney. Moreover, the rate of inactivation was lower in old mice, 28 weeks after the birth, than in younger ones, 5 weeks or 3 weeks. These results suggest that toxicity from bleomycin would appear in skin and lung and more frequently in older patients. This is in accord with clinical observations. The bleomycin-inactivating enzyme which was partially purified from mice liver was confirmed to release one mole of ammoniafrom carboxyl amide in bleomycin molecules. The induction of this enzyme by administration of bleomycin to mice could not be observed. The data indicate that this enzyme activity in lung and skin of young mice decreases with the age. Though it is not certain, this enzyme may have some physiological role.
Studies of mode of actions of antitumor compounds have indicated that antitumor compounds are generally very toxic to animal cells.
Generally, they inhibit directly or indirectly nucleic acid or protein synthesis or interfere with the function of the cell membrane. Therefore, it is thought that such antitumor compounds can not be used for treatment of all kinds of human tumors. However, in the study of bleomycin, we found that even an antitumor compound with such characteristics had the possibility of effectiveness against particular types of human cancer. Cells in which an antitumor compound distributes at particularly high concentration, cells which have particularly high ability to activate an antitumor compound, cells which have particularly low ability to inactivate an antitumor compound,or cells in which an enzymesystem relating to the action of the compoundis particularly low or high, are selectively inhibited by such a compound, and a cancer composed of such cells having any of such abilities may be successfully treated by such an antitumor compound. Information of the distribution of antitumor compounds among organs and tissues of experimental animals, on inactivation and activation and on distribution in cells of certain type of experimental tumors can be extremely useful in predicting the type of human tumor which is likely to a response.
Such a type of study on each antitumor compoundis thought to be one of ways to find a useful chemotherapeutic agents against human tumors.
